Ordaos, Inc. — Form D
Ordaos, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-09-11. The offering totals $4.0M, of which $3.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-09-11
- Form: D
- Accession: 0001933700-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $4.0M
- Amount sold: $3.1M
- Remaining: $895K
- Minimum investment: $30K
- Investors: 5
- Date of first sale: 2024-08-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-523756
Issuer
- Name: Ordaos, Inc.
- CIK: 0001933700
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 228 Park Avenue S, NEW YORK, NY, 10003
- Phone: 201-696-5358
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| David Longo | Director | Calgary, A0 |
| David Longo | Executive Officer | Calgary, A0 |
| Ulo Palm | Director | New York, NY |
| Benjamin Britt | Director | New York, NY |
| James Ramey | Director | Blacksburg, VA |
| Scott Horner | Director | Arlington, VA |
Other filings by this issuer (5)
More